R-spondins are newly recognized players in osteoarthritis that regulate Wnt signaling in osteoblasts

Arthritis and Rheumatism

Volumn 63, Issue 12, 2011, Pages 3865-3875

  Abed, Élie ^a   Chan, Thomas F ^a   Delalandre, Aline ^a   Martel Pelletier, Johanne ^a   Pelletier, Jean Pierre ^a   Lajeunesse, Daniel ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; PROTEIN RSPO 1; PROTEIN RSPO 2; T CELL FACTOR PROTEIN; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WNT3A PROTEIN;

AGED; ARTICLE; BONE DEVELOPMENT; BONE TISSUE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MINERALIZATION; OSTEOARTHRITIS; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CELLS, CULTURED; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; OSTEOBLASTS; SIGNAL TRANSDUCTION; THROMBOSPONDINS; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS; WNT SIGNALING PATHWAY; WNT3 PROTEIN;

EID: 82455210448     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30625     Document Type: Article

References (50)

1. Poole RA: Cartilage in health and disease. In: Arthritis and allied conditions: a textbook of rheumatology. Edited by, D McCarty, WJ Koopman,. Philadelphia: Lea & Febiger; 1993. p. 279-335.
2. Dieppe P, Cushnaghan J, Young P, Kirwan J,. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993; 52: 557-63. (Pubitemid 23246656)
3. Wluka AE, Hanna F, Davies-Tuck M, Wang Y, Bell RJ, Davis SR, et al. Bone marrow lesions predict increase in knee cartilage defects and loss of cartilage volume in middle-aged women without knee pain over 2 years. Ann Rheum Dis 2009; 68: 850-5.
4. Roemer FW, Guermazi A, Javaid MK, Lynch JA, Niu J, Zhang Y, et al, for the MOST Study investigators. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study, a longitudinal multicentre study of knee osteoarthritis. Ann Rheum Dis 2009; 68: 1461-5.
5. Hunter DJ, Gerstenfeld L, Bishop G, Davis AD, Mason ZD, Einhorn TA, et al. Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther 2009; 11: R11.
6. Burr DB, Schaffler MB,. The involvement of subchondral mineralized tissues in osteoarthrosis: quantitative microscopic evidence. Microsc Res Tech 1997; 37: 343-57. (Pubitemid 27247062)
7. Carlsson A, Nillson BE, Westlin NE,. Bone mass in primary coxarthrosis. Acta Orthop Scand 1979; 50: 187-9. (Pubitemid 9181268)
8. Gotfriedsen A, Riis BJ, Christiansen C, Rodbro P,. Does a single local absorptiometric measurement indicate the overall skeletal status? Implications for osteoporosis and osteoarthritis of the hip. Clin Rheumatol 1990; 9: 193-203. (Pubitemid 20333817)
9. Bruckner P, Dreier R, Grassel S, Babarina AV,. Common denominators of osteoarthritis and of endochondral bone formation: is osteoarthritis nothing but an inappropriate attempt at bone formation? Z Rheumatologie 2002; 61: 263-5. (Pubitemid 34717803)
10. Aspden RM,. Osteoarthritis: a problem of growth not decay? Rheumatology (Oxford) 2008; 47: 1452-60.
11. Mansell JP, Bailey AJ,. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest 1998; 101: 1596-603. (Pubitemid 28198488)
12. Li B, Aspden RM,. Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis. J Bone Miner Res 1997; 12: 641-51. (Pubitemid 27155224)
13. Bailey AJ, Sims TJ, Knott L,. Phenotypic expression of osteoblast collagen in osteoarthritic bone: production of type I homotrimer. Int J Biochem Cell Biol 2002; 34: 176-82. (Pubitemid 34112526)
14. 2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients? Osteoarthritis Cartilage 2002; 10: 491-500. (Pubitemid 34679302)
15. Erlebacher A, Filvaroff EH, Gitelman SE, Derynck R,. Toward a molecular understanding of skeletal development. Cell 1995; 80: 371-8.
16. Moon RT, Kohn AD, De Ferrari GV, Kaykas A,. WNT and β-catenin signaling: diseases and therapies. Nat Rev Genet 2004; 5: 691-701. (Pubitemid 39150127)
17. Zamurovic N, Cappellen D, Rohner D, Susa M,. Coordinated activation of notch, Wnt, and transforming growth factor-β signaling pathways in bone morphogenic protein 2-induced osteogenesis: notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 2004; 279: 37704-15. (Pubitemid 39195484)
18. Laitinen M, Halttunen T, Jortikka L, Teronen O, Sorsa T, Lindholm TS,. The role of transforming growth factor-β in retarded osteoblastic differentiation in vitro. Life Sci 1999; 64: 847-58. (Pubitemid 29100052)
19. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S,. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 2003; 18: 1842-53. (Pubitemid 37322562)
20. Chan T, Couchourel D, Delalandre A, Duval N, Lajeunesse D,. Elevated Dickkopf-2 levels contribute to the abnormal phenotype of human osteoarthritic osteoblasts. J Bone Miner Res 2011. E-pub ahead of print.
21. Kim KA, Zhao J, Andarmani S, Kakitani M, Oshima T, Binnerts ME, et al. R-spondin proteins: a novel link to β-catenin activation. Cell Cycle 2006; 5: 23-6.
22. Parr BA, Shea MJ, Vassileva G, McMahon AP,. Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development 1993; 119: 247-61. (Pubitemid 23279143)
23. Nam JS, Turcotte TJ, Yoon JK,. Dynamic expression of R-spondin family genes in mouse development. Gene Expr Patterns 2007; 7: 306-12. (Pubitemid 44835278)
24. Aoki M, Kiyonari H, Nakamura H, Okamoto H,. R-spondin2 expression in the apical ectodermal ridge is essential for outgrowth and patterning in mouse limb development. Dev Growth Differ 2008; 50: 85-95.
25. Yamada W, Nagao K, Horikoshi K, Fujikura A, Ikeda E, Inagaki Y, et al. Craniofacial malformation in R-spondin2 knockout mice. Biochem Biophys Res Commun 2009; 381: 453-8.
26. Kim KA, Wagle M, Tran K, Zhan X, Dixon MA, Liu S, et al. R-spondin family members regulate the Wnt pathway by a common mechanism. Mol Biol Cell 2008; 19: 2588-96.
27. Lu W, Kim KA, Liu J, Abo A, Feng X, Cao X, et al. R-spondin1 synergizes with Wnt3a in inducing osteoblast differentiation and osteoprotegerin expression. FEBS Lett 2008; 582: 643-50.
28. Friedman MS, Oyserman SM, Hankenson KD,. Wnt11 promotes osteoblast maturation and mineralization through R-spondin 2. J Biol Chem 2009; 284: 14117-25.
29. Kazanskaya O, Glinka A, del Barco Barrantes I, Stannek P, Niehrs C, Wu W,. R-Spondin2 is a secreted activator of Wnt/β-catenin signaling and is required for Xenopus myogenesis. Dev Cell 2004; 7: 525-34. (Pubitemid 39341838)
30. Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D,. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 1998; 41: 891-9. (Pubitemid 28225790)
31. 4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis Rheum 2002; 46: 1804-12. (Pubitemid 34774512)
32. Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier J-P, et al. Altered mineralization of human osteoarthritic osteoblasts is due to abnormal type I collagen production. Arthritis Rheum 2009; 60: 1438-50.
33. 2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. J Bone Miner Res 2001; 16: 713-21. (Pubitemid 32230600)
34. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
35. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85. (Pubitemid 16258399)
36. Gregory CA, Gunn WG, Peister A, Prockop DJ,. An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004; 329: 77-84. (Pubitemid 38596903)
37. Massicotte F, Fernandes JC, Martel-Pelletier J, Pelletier JP, Lajeunesse D,. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone 2006; 38: 333-41. (Pubitemid 43255427)
38. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-β1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003; 278: 34387-94.
39. Aspden RM, Scheven BAA, Hutchison JD,. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 2001; 357: 1118-20. (Pubitemid 32322547)
40. Lajeunesse D, Reboul P,. Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling. Curr Opin Rheumatol 2003; 15: 628-33. (Pubitemid 37041404)
41. Ding M, Danielsen CC, Hvid I,. Bone density does not reflect mechanical properties in early-stage arthrosis. Acta Orthop Scand 2001; 72: 181-5. (Pubitemid 32402334)
42. Massicotte F, Aubry I, Martel-Pelletier J, Pelletier JP, Fernandes J, Lajeunesse D,. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther 2006; 8: R177.
43. Mutabaruka MS, Aoulad Aissa M, Delalandre A, Lavigne M, Lajeunesse D,. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res Ther 2010; 12: R20.
44. Couchourel D, Delalandre A, Lajeunesse D,. Increased expression of Wnt inhibitory factors in subchondral osteoblasts from osteoarthritic patients could play a role in their abnormal phenotype and mineralization [abstract]. Ann Rheum Dis 2008; 67 Suppl II: 98.
45. Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB,. Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 2002; 169: 507-14. (Pubitemid 34686173)
46. Van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB,. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-β injections. Osteoarthritis Cartilage 2002; 8: 25-33. (Pubitemid 30032724)
47. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM,. BMP-2-induced osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003; 309: 689-94. (Pubitemid 37083307)
48. Niehrs C,. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006; 25: 7469-81. (Pubitemid 44885746)
49. Fujita K, Janz S,. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer 2007; 6: 71.
50. Attur MG, Palmer GD, Al-Mussawir HE, Dave M, Teixeira CC, Rifkin DB, et al. F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-β activation. FASEB J 2009; 23: 79-89.